GE HealthCare to Present AI-Enhanced Oncology Solutions at ESTRO 2024 Congress

May 2, 2024: GE HealthCare has announced a new computed tomography (CT) with radiation therapy solution with innovative hardware and software solutions to help increase imaging accuracy. A statement on the presentation of Revolution RT(i), which will take place at the upcoming European Society for Radiology and Therapeutic Oncology (ESTRO) Congress 2024 in Glasgow from May 3 to 7, reports that the solution simplifies workflow simulation for a more personalized and seamless experience in the oncology care pathway for doctors and patients.

Along with the introduction of the new Revolution RT, GE HealthCare is also unveiling an updated and enhanced artificial intelligence (AI) version of its intelligent radiation therapy (iRT) platform, which interfaces with the Spectronic magnetic resonance imaging (MRI) planner. Additionally, the company will showcase its recently acquired MIM software portfolio and other key innovations.

One of the greatest challenges in oncology care is the complexity of the disease, both in the many varieties of cancer and in the different ways in which it can present in each individual patient(ii), which requires diligence and personalization in diagnosis and treatment. treatment. Additionally, the company’s written statement notes, treatment often requires the expertise of multiple disciplines and experts related to specific organs and systems of the body, resulting in potential delays in diagnosis and timely treatment. According to research published by the British Medical Journal (BMJ), the risk of mortality increases between 6% and 13% for each month that the diagnosis is delayed(iii), so it is essential to streamline the complex path of oncological care and reduce the time elapsed since diagnosis. to treatment, ultimately leading to better outcomes for patients.

“We are committed to advancing the frontiers of oncology treatment through AI-powered technologies that transform and optimize the continuum of care,” said Dr. Taha Kass-Hout, chief technology and science officer at GE HealthCare. “Our exhibit at ESTRO this year highlights innovations that will allow doctors to see a patient’s anatomy with great precision, which will help facilitate precise tumor localization while protecting nearby healthy tissue. By integrating these capabilities into our systems, we create an accurate, more connected and efficient care environment that accelerates the delivery of personalized care, with the goal of enabling better patient outcomes. This comprehensive approach allows doctors around the world to address the most challenging diseases with precision and efficiency,” he added.

GE HealthCare’s novel radiation therapy solutions and recent acquisition of the MIM software portfolio are designed to reshape the oncology experience around the needs of providers and their patients across the cancer care continuum:

GE HealthCare reports that its teams designed its new Revolution RT with a large-bore CT platform and high-throughput radiation therapy simulation, diagnosis and intervention capabilities to serve more patients and create a more optimized standard of care. Revolution RT includes precision radiation therapy simulation that will help enable more accurate imaging, while improving workflow and efficiency, and uses deep learning technology to help accurately image the patient.

Updated smart radiation therapy (iRT)

At ESTRO 2024, GE HealthCare will also showcase the newly updated iRT platform, first launched at ESTRO 2023. The solution, the company noted, enables greater interoperability, connectivity and efficiency across the entire radiation oncology care continuum and includes key features . such as an integrated workflow that connects multiple applications into a single intuitive interface, multi-vendor interoperability, seamless data transfer and task automation, and a catalog of RT applications from both GE HealthCare and third parties.

The company is introducing multiple updates to the iRT platform, highlighting its vendor-agnostic ecosystem:

MR Direct (with Spectronic Medical): The Spectronic Medical app, which is integrated into the updated iRT, uses AI to convert simulated MR images into an equivalent CT image that can be used to calculate RT dose.

Simplified Planning (with MIM): Advanced interoperability with automated context launch to simplify pretreatment planning steps, including image visualization, segmentation, and fusion.

InstaPlan (with RaySearch): A novel approach to creating treatment plans while the patient is still on the simulation table. This is a paradigm shift that can potentially reduce the time between simulation and the first radiation dose. GE HealthCare’s collaboration with RaySearch will bring further innovation to treatment planning and simulation workflows to support advances in photon, electron, particle and brachial therapies.

Personalization: The company reports that the newly enhanced version of iRT is updated to allow user-enabled notification, analytics and customization modules.

“The key to better patient outcomes in cancer care requires solutions that simplify and shorten an incredibly complex workflow for providers, as well as personalize the care path for patients, to ensure more efficient care.” effective for each individual,” said Dr. Ben Newton. , CEO of Oncology at GE HealthCare. Newton added: “GE HealthCare worked closely with physicians around the world to develop the iRT platform that streamlines the radiation therapy pathway by connecting disparate application systems from multiple vendors, creating a vendor-agnostic ecosystem, and leveraging the power of AI to potentially reduce the critical time between treatment planning and first treatment.”

GE HealthCare recently announced the closing of its acquisition of MIM Software and the addition of its image analysis and digital workflow offerings as part of the company’s portfolio. MIM Software’s clinical tools, combined with GE HealthCare imaging solutions, provide greater flexibility, automation and efficiency for providers. This includes the addition of MIM Software’s radiation oncology portfolio, which is designed to provide physicians with complementary interoperable solutions that can help simplify complex planning and deliver faster treatment.

According to the statement released before ESTRO, the acquisition of MIM enabled the expansion of GE HealthCare’s relationship with Elekta, a leader in precision radiation oncology. GE HealthCare’s MIM software portfolio will enhance Elekta’s innovative treatment planning software, which assists in the delivery of radiation therapy by enabling accurate dose calculation. The collaboration is expected to leverage MIM Software and Elekta’s respective strengths in regional markets to make the solutions available globally.

References:

(Yo) This product is not CE marked and cannot be placed on the market or put into service until it has been manufactured to comply with the CE mark.

(ii) American Association for Cancer Research. The complexities of cancer explained for the benefit of the patient. Available at: https://www.aacr.org/blog/2015/05/26/complexities-of-cancer-explained-for-patient-benefit/#:~:text=One%20of%20the%20biggest%20complexities ,organs%20often%20behave%20very%20differently. Last accessed February 2023.

(iii) TP Hanna, WD King, S. Thibodeau, M. Jalink, GA Paulin, E. Harvey-Jones, DE O’Sullivan, CM Booth, R. Sullivan, A. Aggarwal. Mortality due to delay in cancer treatment: systematic review and meta-analysis. The BMJ. DOI: 10.1136/bmj.m4087

(v) CT sub-segment dashboard based on COCIR, Ispos, EMA, JP-KPI sources.

More information: www.gehealthcare.com